Advertisement

Search Results

Advertisement



Your search for Caroline Helwick matches 4 pages

Showing 1 - 4


lung cancer

WCLC: Bevacizumab Plus Standard Chemotherapy Improves Survival in Mesothelioma

The standard of care for malignant pleural mesothelioma may be poised for change, judging by results from a study (Abstract ORAL11.01) by the French Cooperative Thoracic Intergroup. The addition of bevacizumab (Avastin) in the first-line setting to the current standard of care, pemetrexed...

lung cancer

Investigational EGFR Inhibitor May Hold Promise for Some Patients With Treatment-Resistant NSCLC

Approximately 50% of non–small cell lung cancer (NSCLC) patients who develop resistance to inhibitors of the epidermal growth factor receptor (EGFR) have acquired a second mutation, T790M, which no current EGFR inhibitors target. This may change if the AstraZeneca investigational compound...

lung cancer
issues in oncology

Simple Blood Test May Diagnose Lung and Other Cancers

A simple blood test that measures serum free fatty acids and their metabolites may detect early-stage lung cancer and its recurrence, according to a study from The Cleveland Clinic presented at the ANESTHESIOLOGY™ 2013 Annual Meeting in San Francisco (Abstract A4267). The study was presented ...

lung cancer
issues in oncology

Best of ASCO 2013: VeriStrat Assay May Help Select NSCLC Patients for Second-Line Therapy

VeriStrat, a serum-based protein assay, can help select which patients with non–small cell lung cancer (NSCLC) who are not known to have epidermal growth factor receptor (EGFR) mutations might benefit from an EGFR-targeted agent, according to a study described at the 2013 Best of ASCO Los...

Advertisement

Advertisement



Advertisement